While the exact causes of neurodegenerative brain diseases like Alzheimer's and dementia are still largely unknown, researchers have been able to identify a key characteristic in affected brains: ...

Last month, The US Food and Drug Administration approved a new blood test for assisting the diagnosis of Alzheimer’s disease. Produced by Roche, Elecsys pTau181 measures the concentration of a ...

The following essay is reprinted with permission from The Conversation, an online publication covering the latest research. In a routine blood test that turned extraordinary, French scientists have ...

Circulate Health, a Seattle healthy longevity startup, today announced $12 million in seed funding. The company is partnering with two-dozen clinics in eight states to provide a blood-cleaning service ...

Haupt is a health and wellness editor at TIME. Function Health CEO Jonathan Swerdlin Many people have low-level risk factors, such as early signs of heart disease, smoldering inside their body. But ...

Erythritol may impair cellular functions essential to maintaining brain blood vessel health, according to researchers at the University of Colorado Boulder. Findings suggest that erythritol increases ...

A small new study offers insight into plasma exchange therapy. By Mohana Ravindranath Cars need oil changes to keep their engines running smoothly. Some anti-aging influencers, along with a handful of ...

The very first blood test for Alzheimer's disease detection has been green-lit by the US Food and Drug Administration (FDA), providing a simpler and less invasive method for early diagnosis and ...

The FDA said it has issued its first official green light for a blood test to help diagnose Alzheimer’s disease, adding that it can help reduce the need for invasive samples or expensive PET scans.

The US Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, making the test the first to get signoff to aid in the early detection of the ...

Paid plasma centers, like Octapharma and Biomat USA, offer compensation ranging from $175-$200 for the first two visits, then $40-$65 per visit. Community Blood Bank provides plasma directly to ...